MOH
- Marketing authorisation holder: MEDPOINTE PHARM HLC
- Status: likely_approved
🇮🇱 Mebutina in Israel
Mebutina (MEBUTAMATE) regulatory status in Israel.
Marketing authorisation
Mebutina in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in Israel
Frequently asked questions
Is Mebutina approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Mebutina in Israel?
MEDPOINTE PHARM HLC holds the Israeli marketing authorisation.